2007•Medical Journal of Chinese People's HealthRequires access

Comparative study between venlafaxine and paroxetine in treatment of depression

Jingbo Song

Open publisher page 0 citations

Abstract

Objective:To evaluate the efficacy and side effect of venlafaxine in the treatment of depression.Methods:63 out-patients and in-patients were divided into two groups,treated by venlafaxine and paroxetine respectively for 6 weeks.The efficacy was assessed by Hamilton depression rating scale(HAMD) and the safety was assessed by Rating Scale for Side Effects(SERS).Results: After 6 weeks treatment,the efficacy rate of the venlafaxine group and paroxetine group were 80.6% and 74.2%,respectively.The results have no remarkable differences in two groups(P0.05).but venlafaxine group's convalescing rate achieved 51.6% and the paroxetine group 25.8%,The results have remarkable differences in two groups﹝P0.05).And the paroxetine group took effect more quickly.Conclusions: Venlafaxine is a safe and effective antidepressant.It has faster efficacy.

About this research paper

What this paper is about

Objective:To evaluate the efficacy and side effect of venlafaxine in the treatment of depression.Methods:63 out-patients and in-patients were divided into two groups,treated by venlafaxine and paroxetine respectively for 6 weeks.The efficacy was assessed by Hamilton depression rating scale(HAMD) and the safety was assessed by Rating Scale for Side Effects(SERS).Results: After 6 weeks treatment,the efficacy rate of the venlafaxine group and paroxetine group were 80.6% and 74.2%,respectively.The results have no remarkable differences in two groups(P0.05).but venlafaxine group's convalescing rate achieved 51.6% and the paroxetine group 25.8%,The results have remarkable differences in two groups﹝P0.05).And the paroxetine group took effect more quickly.Conclusions: Venlafaxine is a safe and effective antidepressant.It has faster efficacy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the efficacy and side effect of venlafaxine in the treatment of depression.Methods:63 out-patients and in-patients were divided into two groups,treated by venlafaxine and paroxetine respectively for 6 weeks.The efficacy was assessed by Hamilton depression rating scale(HAMD) and the safety was assessed by Rating Scale for Side Effects(SERS).Results: After 6 weeks treatment,the efficacy rate of the venlafaxine group and paroxetine group were 80.6% and 74.2%,respectively.The results have no remarkable differences in two groups(P0.05).but venlafaxine group's convalescing rate achieved 51.6% and the paroxetine group 25.8%,The results have remarkable differences in two groups﹝P0.05).And the paroxetine group took effect more quickly.Conclusions: Venlafaxine is a safe and effective antidepressant.It has faster efficacy.

Key concepts: Paroxetine, Venlafaxine, Hamd, Rating scale, Depression (economics), Antidepressant, Internal medicine, Hamilton depression scale

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study between venlafaxine and paroxetine in treatment of depression — Research Paper | ScholarLens